Innate Pharma S.A. (EPA:IPH)
1.810
-0.002 (-0.11%)
Apr 1, 2025, 12:32 PM CET
Innate Pharma Employees
Innate Pharma had 181 employees as of December 31, 2024. The number of employees increased by 2 or 1.12% compared to the previous year.
Employees
181
Change (1Y)
2
Growth (1Y)
1.12%
Revenue / Employee
€111,166
Profits / Employee
€273,320
Market Cap
151.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 13,982 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,459 |
emeis Société anonyme | 77,954 |
Innate Pharma News
- 12 days ago - Innate Pharma Announces Conference Call and Webcast for Full Year 2024 Financial Results - Business Wire
- 4 weeks ago - Innate Pharma to Participate in the 2025 Leerink Partners Global Healthcare Conference - Business Wire
- 5 weeks ago - Innate: Lacutamab Treatment Program Moves Forward With Potential Expansion - Seeking Alpha
- 5 weeks ago - Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments - Seeking Alpha
- 6 weeks ago - Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome - Business Wire
- 2 months ago - Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
- 2 months ago - Innate Pharma Announces First Patient Dosed in Phase 1 Study of Its Nectin-4 Targeting Antibody Drug Conjugate IPH4502 in Selected Advanced Solid Tumors - Business Wire
- 2 months ago - Innate Pharma Announces Nectin-4 Antibody Drug Conjugate Investor and Analyst Event in New York - Business Wire